3/20
08:44 am
lrmr
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $12.00 to $13.00. They now have an "outperform" rating on the stock.
Low
Report
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $12.00 to $13.00. They now have an "outperform" rating on the stock.
3/19
07:24 am
lrmr
Larimar Therapeutics GAAP EPS of -$0.73 misses by $0.22 [Seeking Alpha]
Medium
Report
Larimar Therapeutics GAAP EPS of -$0.73 misses by $0.22 [Seeking Alpha]
3/19
07:00 am
lrmr
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3/4
04:05 pm
lrmr
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Medium
Report
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
3/4
08:57 am
lrmr
Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]
Low
Report
Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]
3/3
10:18 am
lrmr
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $11.00 to $12.00. They now have an "outperform" rating on the stock.
Low
Report
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $11.00 to $12.00. They now have an "outperform" rating on the stock.
2/28
11:22 am
lrmr
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? [Yahoo! Finance]
2/25
08:59 pm
lrmr
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Medium
Report
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
3/19/2026
07:00 am
lrmr
larimar therapeutics, inc.
MISS
Report
3.7%
larimar therapeutics, inc.
11/5/2025
07:00 am
lrmr
larimar therapeutics, inc.
MISS
Report
-8.0%
larimar therapeutics, inc.
8/14/2025
07:00 am
lrmr
larimar therapeutics, inc.
BEAT
Report
14.5%
larimar therapeutics, inc.
3/24/2025
07:00 am
lrmr
larimar therapeutics, inc.
MISS
Report
-13.0%
larimar therapeutics, inc.
3/19
05:03 pm
lrmr
Form S-8 Larimar Therapeutics,
Low
Report
Form S-8 Larimar Therapeutics,
3/19
03:42 pm
lrmr
Form 10-K Larimar Therapeutics, For: Dec 31
Low
Report
Form 10-K Larimar Therapeutics, For: Dec 31
3/19
07:04 am
lrmr
Form 8-K Larimar Therapeutics, For: Mar 19
Medium
Report
Form 8-K Larimar Therapeutics, For: Mar 19
3/2
07:47 pm
lrmr
Form SCHEDULE 13D/A Larimar Therapeutics, Filed by: Flynn James E
Low
Report
Form SCHEDULE 13D/A Larimar Therapeutics, Filed by: Flynn James E
3/2
07:46 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Deerfield Mgmt HIF, L.P.
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Deerfield Mgmt HIF, L.P.
3/2
04:31 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: THOMAS FRANK E
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: THOMAS FRANK E
3/2
04:31 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Hamilton Thomas Edward
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: Hamilton Thomas Edward
3/2
04:31 pm
lrmr
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: SHERMAN JEFFREY W
Low
Report
Form 4 Larimar Therapeutics, For: Feb 27 Filed by: SHERMAN JEFFREY W
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register